33 results on '"Baak R"'
Search Results
2. PO-1720 Inter- and intrafraction dose variations in perihilar cholangiocarcinoma SBRT in the STRONG trial
- Author
-
Paronetto, C., primary, Den Toom, W., additional, Milder, M.T., additional, van Norden, Y., additional, Baak, R., additional, Heijmen, B.J., additional, and Méndez Romero, A., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Stereotactic Body Radiation Therapy Following Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Feasibility Study
- Author
-
Baak, R., primary, Willemssen, F.E.J.A., additional, van Norden, Y., additional, Milder, M., additional, Heijmen, B.J.M., additional, Eskens, F.A.L.M., additional, Koerkamp, B. Groot, additional, Sprengers, D., additional, van Driel, L.M.J.W., additional, Klümpen, H.J., additional, den Toom, W., additional, Koedijk, M.S., additional, and Romero, A. Mendez, additional
- Published
- 2021
- Full Text
- View/download PDF
4. The effect of immediate coronary angiography after cardiac arrest without ST-segment elevation on left ventricular function. A sub-study of the COACT randomised trial
- Author
-
Lemkes, J.S., Spoormans, E.M., Demirkiran, A., Leutscher, S., Janssens, G.N., Hoeven, N.W. Van Der, Jewbali, L.S.D., Dubois, E.A., Meuwissen, M., Rijpstra, T.A., Bosker, H.A., Blans, M.J., Bleeker, G.B., Baak, R., Vlachojannis, G.J., Eikemans, B.J.W., Harst, P. van der, Horst, I.C. van der, Voskuil, M., Heijden, J.J. van der, Beishuizen, A., Stoel, M., Camaro, C., Hoeven, H. van der, Henriques, J.P.S., Vlaar, A.P.J., Vink, Matthijs, Bogaard, B. van den, Heestermans, T., Ruijter, W. de, Delnoij, T.S.R., Crijns, H., Jessurun, G.A., Oemrawsingh, P.V., Gosselink, M.T.M., Plomp, K., Magro, M., Elbers, P.W.G., Ven, P.M. van de, Loon, R.B. van, Royen, N. van, Lemkes, J.S., Spoormans, E.M., Demirkiran, A., Leutscher, S., Janssens, G.N., Hoeven, N.W. Van Der, Jewbali, L.S.D., Dubois, E.A., Meuwissen, M., Rijpstra, T.A., Bosker, H.A., Blans, M.J., Bleeker, G.B., Baak, R., Vlachojannis, G.J., Eikemans, B.J.W., Harst, P. van der, Horst, I.C. van der, Voskuil, M., Heijden, J.J. van der, Beishuizen, A., Stoel, M., Camaro, C., Hoeven, H. van der, Henriques, J.P.S., Vlaar, A.P.J., Vink, Matthijs, Bogaard, B. van den, Heestermans, T., Ruijter, W. de, Delnoij, T.S.R., Crijns, H., Jessurun, G.A., Oemrawsingh, P.V., Gosselink, M.T.M., Plomp, K., Magro, M., Elbers, P.W.G., Ven, P.M. van de, Loon, R.B. van, and Royen, N. van
- Abstract
Item does not contain fulltext, BACKGROUND: The effect of immediate coronary angiography and percutaneous coronary intervention (PCI) in patients who are successfully resuscitated after cardiac arrest in the absence of ST-segment elevation myocardial infarction (STEMI) on left ventricular function is currently unknown. METHODS: This prespecified sub-study of a multicentre trial evaluated 552 patients, successfully resuscitated from out-of-hospital cardiac arrest without signs of STEMI. Patients were randomized to either undergo immediate coronary angiography or delayed coronary angiography, after neurologic recovery. All patients underwent PCI if indicated. The main outcomes of this analysis were left ventricular ejection fraction and end-diastolic and systolic volumes assessed by cardiac magnetic resonance imaging or echocardiography. RESULTS: Data on left ventricular function was available for 397 patients. The mean (± standard deviation) left ventricular ejection fraction was 45.2% (±12.8) in the immediate angiography group and 48.4% (±13.2) in the delayed angiography group (mean difference: -3.19; 95% confidence interval [CI], -6.75 to 0.37). Median left ventricular end-diastolic volume was 177 ml in the immediate angiography group compared to 169 ml in the delayed angiography group (ratio of geometric means: 1.06; 95% CI, 0.95-1.19). In addition, mean left ventricular end-systolic volume was 90 ml in the immediate angiography group compared to 78 ml in the delayed angiography group (ratio of geometric means: 1.13; 95% CI 0.97-1.32). CONCLUSION: In patients successfully resuscitated after out-of-hospital cardiac arrest and without signs of STEMI, immediate coronary angiography was not found to improve left ventricular dimensions or function compared with a delayed angiography strategy. CLINICAL TRIAL REGISTRATION: Netherlands Trial Register number, NTR4973.
- Published
- 2021
5. Sex differences in patients with out-of-hospital cardiac arrest without ST-segment elevation: A COACT trial substudy
- Author
-
Spoormans, E.M., Lemkes, J.S., Janssens, G.N., Hoeven, N.W. Van Der, Jewbali, L.S.D., Dubois, E.A., Ven, P.M. van de, Meuwissen, M., Rijpstra, T.A., Bosker, H.A., Blans, M.J., Bleeker, G.B., Baak, R., Vlachojannis, G.J., Eikemans, B.J.W., Harst, P.V. der, Horst, I.C. van der, Voskuil, M., Heijden, J.J. van der, Beishuizen, A., Stoel, M., Camaro, C., Hoeven, H. van der, Henriques, J.P.S., Vlaar, A.P.J., Vink, Matthijs, Bogaard, B. van den, Heestermans, T., Ruijter, W. de, Delnoij, T.S.R., Crijns, H., Jessurun, G.A., Oemrawsingh, P.V., Gosselink, M.T.M., Plomp, K., Magro, M., Elbers, P.W.G., Appelman, Y., Royen, N. van, Spoormans, E.M., Lemkes, J.S., Janssens, G.N., Hoeven, N.W. Van Der, Jewbali, L.S.D., Dubois, E.A., Ven, P.M. van de, Meuwissen, M., Rijpstra, T.A., Bosker, H.A., Blans, M.J., Bleeker, G.B., Baak, R., Vlachojannis, G.J., Eikemans, B.J.W., Harst, P.V. der, Horst, I.C. van der, Voskuil, M., Heijden, J.J. van der, Beishuizen, A., Stoel, M., Camaro, C., Hoeven, H. van der, Henriques, J.P.S., Vlaar, A.P.J., Vink, Matthijs, Bogaard, B. van den, Heestermans, T., Ruijter, W. de, Delnoij, T.S.R., Crijns, H., Jessurun, G.A., Oemrawsingh, P.V., Gosselink, M.T.M., Plomp, K., Magro, M., Elbers, P.W.G., Appelman, Y., and Royen, N. van
- Abstract
Item does not contain fulltext, BACKGROUND: Whether sex is associated with outcomes of out-of-hospital cardiac arrest (OHCA) is unclear. OBJECTIVES: This study examined sex differences in survival in patients with OHCA without ST-segment elevation myocardial infarction (STEMI). METHODS: Using data from the randomized controlled Coronary Angiography after Cardiac Arrest (COACT) trial, the primary point of interest was sex differences in OHCA-related one-year survival. Secondary points of interest included the benefit of immediate coronary angiography compared to delayed angiography until after neurologic recovery, angiographic and clinical outcomes. RESULTS: In total, 522 patients (79.1% men) were included. Overall one-year survival was 59.6% in women and 63.4% in men (HR 1.18; 95% CI: 0.76-1.81;p = 0.47). No cardiovascular risk factors were found that modified survival. Women less often had significant coronary artery disease (CAD) (37.0% vs. 71.3%;p < 0.001), but when present, they had a worse prognosis than women without CAD (HR 3.06; 95% CI 1.31-7.19;p = 0.01). This was not the case for men (HR 1.05; 95% CI 0.67-1.65;p = 0.83). In both sexes, immediate coronary angiography did not improve one-year survival compared to delayed angiography (women, odds ratio (OR) 0.87; 95% CI 0.58-1.30;p = 0.49; vs. men, OR 0.97; 95% CI 0.45-2.09;p = 0.93). CONCLUSION: In OHCA patients without STEMI, we found no sex differences in overall one-year survival. Women less often had significant CAD, but when CAD was present they had worse survival than women without CAD. This was not the case for men. Both sexes did not benefit from a strategy of immediate coronary angiography as compared to delayed strategy with respect to one-year survival. CLINICAL TRIAL REGISTRATION NUMBER: Netherlands trial register (NTR) 4973.
- Published
- 2021
6. Data on sex differences in one-year outcomes of out-of-hospital cardiac arrest patients without ST-segment elevation
- Author
-
Spoormans, E.M. (Eva M.), Lemkes, J.S. (Jorrit S.), Janssens, G.N. (Gladys N.), van der Hoeven, N.W. (Nina W.), Jewbali, L.S.D. (Lucia), Dubois, E.A., van de Ven, P.M. (Peter M.), Meuwissen, M.M. (M.), Rijpstra, T.A. (Tom A.), Bosker, R.J.I. (Robbert), Blans, M.J. (Michiel J.), Bleeker, G.B. (Gabe), Baak, R. (Remon), Vlachojannis, G.J. (Georgios), Eikemans, B.J.W. (Bob J.W.), Harst, P. (Pim) van der, Van Der Horst, I.C.C. (Iwan C.C.), Voskuil, M. (Michiel), van der Heijden, J.J. (Joris J.), Beishuizen, A. (Albertus), Stoel, M.G., Camaro, C. (Cyril), van der Hoeven, H. (Hans), Henriques, J.P. (José P.), Vlaar, A.P.J. (Alexander), Vink, M.A., Bogaard, B. (Bas) van den, Heestermans, T. (Ton), Ruijter, W. de, Delnoij, T.S.R. (Thijs S.R.), Crijns, H.J. (Harry), Jessurun, G.A. (Gillian), Oemrawsingh, P., Gosselink, M.T.M. (Marcel T.M.), Plomp, K. (Koos), Magro, M. (Michael), Elbers, P.W.G. (Paul W.), Appelman, Y.E.A. (Yolande), Royen, N. (Niels) van, Spoormans, E.M. (Eva M.), Lemkes, J.S. (Jorrit S.), Janssens, G.N. (Gladys N.), van der Hoeven, N.W. (Nina W.), Jewbali, L.S.D. (Lucia), Dubois, E.A., van de Ven, P.M. (Peter M.), Meuwissen, M.M. (M.), Rijpstra, T.A. (Tom A.), Bosker, R.J.I. (Robbert), Blans, M.J. (Michiel J.), Bleeker, G.B. (Gabe), Baak, R. (Remon), Vlachojannis, G.J. (Georgios), Eikemans, B.J.W. (Bob J.W.), Harst, P. (Pim) van der, Van Der Horst, I.C.C. (Iwan C.C.), Voskuil, M. (Michiel), van der Heijden, J.J. (Joris J.), Beishuizen, A. (Albertus), Stoel, M.G., Camaro, C. (Cyril), van der Hoeven, H. (Hans), Henriques, J.P. (José P.), Vlaar, A.P.J. (Alexander), Vink, M.A., Bogaard, B. (Bas) van den, Heestermans, T. (Ton), Ruijter, W. de, Delnoij, T.S.R. (Thijs S.R.), Crijns, H.J. (Harry), Jessurun, G.A. (Gillian), Oemrawsingh, P., Gosselink, M.T.M. (Marcel T.M.), Plomp, K. (Koos), Magro, M. (Michael), Elbers, P.W.G. (Paul W.), Appelman, Y.E.A. (Yolande), and Royen, N. (Niels) van
- Abstract
Sex differences in out-of-hospital cardiac arrest (OHCA) patients are increasingly recognized. Although it has been found that post-resuscitated women are less likely to have significant coronary artery disease (CAD) than men, data on follow-up in these patients are limited. Data for this data in brief article was obtained as a part of the randomized controlled Coronary Angiography after Cardiac Arrest without ST-segment elevation (COACT) trial. The data supplements the manuscript “Sex differences in out-of-hospital cardiac arrest patients without ST-segment elevation: A COACT trial substudy” were it was found that women were less likely to have significant CAD including chronic total occlusions, and had worse survival when CAD was present. The dataset presented in this paper describes sex differences on interventions, implantable-cardioverter defibrillator (ICD) shocks and hospitalizations due to heart failure during one-year follow-up in patients successfully resuscitated after OHCA. Data was derived through a telephone interview at one year with the patient or general practitioner. Patients in this randomized dataset reflects a homogenous study population, which can be valuable to further build on research regarding long-term sex differences and to further improve cardiac care.
- Published
- 2020
- Full Text
- View/download PDF
7. Data on sex differences in one-year outcomes of out-of-hospital cardiac arrest patients without ST-segment elevation
- Author
-
Spoormans, EM, Lemkes, JS, Janssens, GN, van der Hoeven, NW, Jewbali, Lucia, Dubois, Eric, van de Ven, PM, Meuwissen, M, Rijpstra, TA, Bosker, HA, Blans, MJ, Bleeker, GB, Baak, R, Vlachojannis, GJ, Eikemans, BJW, van der Harst, P, van der Horst, ICC, Voskuil, M, van der Heijden, JJ, Beishuizen, A, Stoel, M, Camaro, C, van der Hoeven, H, Henriques, JP, Vlaar, APJ, Vink, MA, van den Bogaard, B, Heestermans, T, de Ruijter, W, Delnoij, TSR, Crijns, H, Jessurun, G A J, Oemrawsingh, PV, Gosselink, MTM, Plomp, K, Magro, M, Elbers, PW, Appelman, Y, Royen, N, Spoormans, EM, Lemkes, JS, Janssens, GN, van der Hoeven, NW, Jewbali, Lucia, Dubois, Eric, van de Ven, PM, Meuwissen, M, Rijpstra, TA, Bosker, HA, Blans, MJ, Bleeker, GB, Baak, R, Vlachojannis, GJ, Eikemans, BJW, van der Harst, P, van der Horst, ICC, Voskuil, M, van der Heijden, JJ, Beishuizen, A, Stoel, M, Camaro, C, van der Hoeven, H, Henriques, JP, Vlaar, APJ, Vink, MA, van den Bogaard, B, Heestermans, T, de Ruijter, W, Delnoij, TSR, Crijns, H, Jessurun, G A J, Oemrawsingh, PV, Gosselink, MTM, Plomp, K, Magro, M, Elbers, PW, Appelman, Y, and Royen, N
- Published
- 2020
8. Mews at the time of ICU discharge is associated with outcome
- Author
-
Meynaar, IA, Huber, P, van den Berg, AE, Vermeulen, J, Toorenburg, K, Melief, P, and Baak, R
- Published
- 2015
- Full Text
- View/download PDF
9. Liquid Distribution Properties of Conventional and High Capacity Structured Packings
- Author
-
Olujić, Ž., Van Baak, R., Haaring, J., Kaibel, B., and Jansen, H.
- Published
- 2006
- Full Text
- View/download PDF
10. Effect of a severe form of initial gas maldistribution on pressure drop of a structured packing bed
- Author
-
Olujić, Ž., Haaring, J.P., and van Baak, R.
- Published
- 2006
- Full Text
- View/download PDF
11. The production of epsom salt from magnesium hydroxide, sulphuric acid and waste magnesium sulphate
- Author
-
Van Baak, R., Bol, E., Cui, X.J., Denkova, A.G., Gielen, R.P., Haaring, J.P., Van der Hoeven, M.J., Regenbogen, M.W., Roestenberg, R.R.W., and Steenbakker, M.J.
- Subjects
epsom salt ,epsomite ,magnesium sulphate ,eutectic freeze crystallisation ,cool crystallisation - Abstract
Document(en) uit de collectie Chemische Procestechnologie
- Published
- 2001
12. Rapid Pharmacogenetic Testing for Clopidogrel Using the INFINITI Analyser: A Dose Escalation Study
- Author
-
Gladding, PA, primary, Webster, MW, additional, Ormiston, J, additional, Stewart, J, additional, Ruygrok, P, additional, Fu, K, additional, and Baak, R, additional
- Published
- 2009
- Full Text
- View/download PDF
13. The production of epsom salt from magnesium hydroxide, sulphuric acid and waste magnesium sulphate
- Author
-
Van Baak, R. (author), Bol, E. (author), Cui, X.J. (author), Denkova, A.G. (author), Gielen, R.P. (author), Haaring, J.P. (author), Van der Hoeven, M.J. (author), Regenbogen, M.W. (author), Roestenberg, R.R.W. (author), Steenbakker, M.J. (author), Van Baak, R. (author), Bol, E. (author), Cui, X.J. (author), Denkova, A.G. (author), Gielen, R.P. (author), Haaring, J.P. (author), Van der Hoeven, M.J. (author), Regenbogen, M.W. (author), Roestenberg, R.R.W. (author), and Steenbakker, M.J. (author)
- Abstract
Document(en) uit de collectie Chemische Procestechnologie, DelftChemTech, Applied Sciences
- Published
- 2001
14. Early results and long-term follow-up after corrective surgery for total anomalous pulmonary venous return.
- Author
-
Boger, A J, Baak, R, Lee, P C, Boersma, E, Meijboom, F J, and Witsenburg, M
- Abstract
An ever increasing number of patients with an operated congenital cardiac anomaly is reaching adulthood. Insight in the long-term characteristics of these patients is steadily growing for the more common anomalies, but is still scarce for the less frequent entities. In this regard we report our results and long-term follow-up of surgically treated total anomalous pulmonary venous return (TAPVR).
- Published
- 1999
- Full Text
- View/download PDF
15. The Prognostic Value of Troponin-T in Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation: A COACT Substudy.
- Author
-
Spoormans EM, Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, van der Pas S, and van Royen N
- Abstract
Background: In out-of-hospital cardiac arrest (OHCA) without ST-elevation, predictive markers that can identify those with a high risk of acute coronary syndrome are lacking., Methods: In this post hoc analysis of the Coronary Angiography after Cardiac Arrest (COACT) trial, the baseline, median, peak, and time-concentration curves of troponin-T (cTnT) (T-AUC) in OHCA patients without ST-elevation were studied. cTnT values were obtained at predefined time points at 0, 3, 6, 12, 24, 36, 28, and 72 hours after admission. All patients who died within the measurement period were not included. The primary outcome was the association between cTnT and 90-day survival. Secondary outcomes included the association of cTnT and acute thrombotic occlusions, acute unstable lesions, and left ventricular function., Results: In total, 352 patients were included in the analysis. The mean age was 64 ± 13 years (80.4% men). All cTnT measures were independent prognostic factors for mortality after adjustment for potential confounders age, sex, history of coronary artery disease, witnessed arrest, time to BLS, and time to return of spontaneous circulation (eg, for T-AUC: hazard ratio, 1.44; 95% CI, 1.06-1.94; P = .02; P value for all variables ≤.02). Median cTnT (odds ratio [OR], 1.58; 95% CI, 1.18-2.12; P = .002) and T-AUC (OR, 2.03; 95% CI, 1.25-3.29; P = .004) were independent predictors for acute unstable lesions. Median cTnT (OR, 1.62; 95% CI, 1.17-2.23; P = .003) and T-AUC (OR, 2.16; 95% CI, 1.27-3.68; P = .004) were independent predictors for acute thrombotic occlusions. CTnT values were not associated with the left ventricular function (eg, for T-AUC: OR, 2.01; 95% CI, 0.65-6.19; P = .22; P value for all variables ≥.14)., Conclusion: In OHCA patients without ST-segment elevation, cTnT release during the first 72 hours after return of spontaneous circulation was associated with clinical outcomes., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
16. Inter- and intrafraction dose variations in robotic stereotactic body radiation therapy (SBRT) for perihilar cholangiocarcinoma in the prospective phase I STRONG trial.
- Author
-
Paronetto C, den Toom W, Milder MTW, van Norden Y, Baak R, Heijmen BJM, and Méndez Romero A
- Abstract
Using fiducial-marker-based robotic respiratory tumor tracking, we treated perihilar cholangiocarcinoma patients in the STRONG trial with 15 daily fractions of 4 Gy. For each of the included patients, in-room diagnostic-quality repeat CTs (rCT) were acquired pre- and post-dose delivery in 6 treatment fractions to analyze inter- and intrafraction dose variations. Planning CTs (pCTs) and rCTs were acquired in expiration breath-hold. Analogous to treatment, spine and fiducials were used to register rCTs with pCTs. In each rCT, all OARs were contoured, and the target was rigidly copied from the pCT based on grey values. The rCTs acquired were used to calculate the doses to be delivered through the treatment-unit settings. On average, target doses in rCTs and pCTs were similar. However, due to target displacements relative to the fiducials in rCTs, 10% of the rCTs showed PTV coverage losses of >10%. Although target coverages had been planned below desired values in order to protect OARs, many pre-rCTs contained OAR constraint violations: 44.4% for the 6 major constraints. Most OAR dose differences between pre- and post-rCTs were not statistically significant. The dose deviations observed in repeat CTs represent opportunities for more advanced adaptive approaches to enhancing SBRT treatment quality., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Paronetto, den Toom, Milder, van Norden, Baak, Heijmen and Méndez Romero.)
- Published
- 2023
- Full Text
- View/download PDF
17. TRIB3 Modulates PPARγ-Mediated Growth Inhibition by Interfering with the MLL Complex in Breast Cancer Cells.
- Author
-
Hernández-Quiles M, Baak R, Orea-Soufi A, Borgman A, den Haan S, Sobrevals Alcaraz P, Jongejan A, van Es R, Velasco G, Vos H, and Kalkhoven E
- Subjects
- Female, Humans, Ligands, PPAR gamma genetics, Protein Serine-Threonine Kinases antagonists & inhibitors, Protein Serine-Threonine Kinases genetics, RNA, Messenger genetics, Repressor Proteins genetics, Transcription Factors, Breast Neoplasms genetics, Cell Cycle Proteins metabolism
- Abstract
Aberrant expression or activity of proteins are amongst the best understood mechanisms that can drive cancer initiation and progression, as well as therapy resistance. TRIB3, a member of the Tribbles family of pseudokinases, is often dysregulated in cancer and has been associated with breast cancer initiation and metastasis formation. However, the underlying mechanisms by which TRIB3 contributes to these events are unclear. In this study, we demonstrate that TRIB3 regulates the expression of PPARγ, a transcription factor that has gained attention as a potential drug target in breast cancer for its antiproliferative actions. Proteomics and phosphoproteomics analyses together with classical biochemical assays indicate that TRIB3 interferes with the MLL complex and reduces MLL-mediated H3K4 trimethylation of the PPARG locus, thereby reducing PPARγ mRNA expression. Consequently, the overexpression of TRIB3 blunts the antiproliferative effect of PPARγ ligands in breast cancer cells, while reduced TRIB3 expression gives the opposite effect. In conclusion, our data implicate TRIB3 in epigenetic gene regulation and suggest that expression levels of this pseudokinase may serve as a predictor of successful experimental treatments with PPARγ ligands in breast cancer.
- Published
- 2022
- Full Text
- View/download PDF
18. Ischaemic electrocardiogram patterns and its association with survival in out-of-hospital cardiac arrest patients without ST-segment elevation myocardial infarction: a COACT trials' post-hoc subgroup analysis.
- Author
-
Spoormans EM, Lemkes JS, Janssens GN, Soultana O, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, van de Ven PM, and van Royen N
- Subjects
- Coronary Angiography methods, Electrocardiography methods, Humans, Troponin T, Out-of-Hospital Cardiac Arrest therapy, ST Elevation Myocardial Infarction
- Abstract
Aims: ST-depression and T-wave inversion are frequently present on the post-resuscitation electrocardiogram (ECG). However, the prognostic value of ischaemic ECG patterns is unknown., Methods and Results: In this post-hoc subgroup analysis of the Coronary Angiography after Cardiac arrest (COACT) trial, the first in-hospital post-resuscitation ECG in out-of-hospital cardiac arrest patients with a shockable rhythm was analysed for ischaemic ECG patterns. Ischaemia was defined as ST-depression of ≥0.1 mV, T-wave inversion in ≥2 contiguous leads, or both. The primary endpoint was 90-day survival. Secondary endpoints were rate of acute unstable lesions, levels of serum troponin-T, and left ventricular function. Of the 510 out-of-hospital cardiac arrest patients, 340 (66.7%) patients had ischaemic ECG patterns. Patients with ischaemic ECG patterns had a worse 90-day survival compared with those without [hazard ratio 1.51; 95% confidence interval (CI) 1.08-2.12; P = 0.02]. A higher sum of ST-depression was associated with lower survival (log-rank = 0.01). The rate of acute unstable lesions (14.5 vs. 15.8%; odds ratio 0.90; 95% CI 0.51-1.59) did not differ between the groups. In patients with ischaemic ECG patterns, maximum levels of serum troponin-T (μg/L) were higher [0.595 (interquartile range 0.243-1.430) vs. 0.359 (0.159-0.845); ratio of geometric means 1.58; 1.13-2.20] and left ventricular function (%) was worse (44.7 ± 12.5 vs. 49.9 ± 13.3; mean difference -5.13; 95% CI -8.84 to -1.42). Adjusted for age and time to return of spontaneous circulation, ischaemic ECG patterns were no longer associated with survival., Conclusion: Post-arrest ischaemic ECG patterns were associated with worse 90-day survival. A higher sum of ST-depression was associated with lower survival. Adjusted for age and time to return of spontaneous circulation, ischaemic ECG patterns were no longer associated with survival., (© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2022
- Full Text
- View/download PDF
19. A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity.
- Author
-
Akin S, Schriek P, van Nieuwkoop C, Neuman RI, Meynaar I, van Helden EJ, Bouazzaoui HE, Baak R, Veuger M, Mairuhu RATA, van den Berg L, van Driel V, Visser LE, de Jonge E, Garrelds IM, Duynstee JFAB, van Rooden JK, Ludikhuize J, Verdonk K, Caliskan K, Jansen T, van Schaik RHN, and Danser AHJ
- Subjects
- Angiotensin-Converting Enzyme 2 genetics, Humans, Renin-Angiotensin System, SARS-CoV-2, Serine Endopeptidases genetics, Aldosterone blood, Angiotensin-Converting Enzyme 2 blood, COVID-19 diagnosis, Renin blood
- Abstract
Background: The severity of COVID-19 after SARS-CoV-2 infection is unpredictable. Angiotensin-converting enzyme-2 (ACE2) is the receptor responsible for coronavirus binding, while subsequent cell entry relies on priming by the serine protease TMPRSS2 (transmembrane protease, serine 2). Although renin-angiotensin-aldosterone-system (RAAS) blockers have been suggested to upregulate ACE2, their use in COVID-19 patients is now considered well tolerated. The aim of our study was to investigate parameters that determine COVID-19 severity, focusing on RAAS-components and variation in the genes encoding for ACE2 and TMPRSS2., Methods: Adult patients hospitalized due to SARS-CoV-2 infection between May 2020 and October 2020 in the Haga Teaching Hospital were included, and soluble ACE2 (sACE2), renin, aldosterone (in heparin plasma) and polymorphisms in the ACE2 and TMPRSS2 genes (in DNA obtained from EDTA blood) were determined., Measurements and Main Results: Out of the 188 patients who were included, 60 were defined as severe COVID-19 (ICU and/or death). These patients more often used antidiabetic drugs, were older, had higher renin and sACE2 levels, lower aldosterone levels and a lower aldosterone/renin ratio. In addition, they displayed the TMPRSS2-rs2070788 AA genotype less frequently. No ACE2 polymorphism-related differences were observed. Multivariate regression analysis revealed independent significance for age, sACE2, the aldosterone/renin ratio, and the TMPRSS2 rs2070788 non-AA genotype as predictors of COVID-19 severity, together yielding a C-index of 0.79. Findings were independent of the use of RAAS blockers., Conclusion: High sACE2, a low aldosterone/renin ratio and having the TMPRSS2 rs2070788 non-AA genotype are novel independent determinants that may help to predict COVID-19 disease severity., Trial Registration: retrospectively registered., (Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.)
- Published
- 2022
- Full Text
- View/download PDF
20. Cost Analysis From a Randomized Comparison of Immediate Versus Delayed Angiography After Cardiac Arrest.
- Author
-
Camaro C, Bonnes JL, Adang EM, Spoormans EM, Janssens GN, van der Hoeven NW, Jewbali LS, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJ, van der Harst P, van der Horst IC, Voskuil M, van der Heijden JJ, Beishuizen B, Stoel M, van der Hoeven H, Henriques JP, Vlaar AP, Vink MA, van den Bogaard B, Heestermans TA, de Ruijter W, Delnoij TS, Crijns HJ, Jessurun GA, Oemrawsingh PV, Gosselink MT, Plomp K, Magro M, Elbers PW, van de Ven PM, Lemkes JS, and van Royen N
- Subjects
- Coronary Angiography methods, Costs and Cost Analysis, Humans, Quality of Life, Treatment Outcome, Out-of-Hospital Cardiac Arrest diagnostic imaging, Out-of-Hospital Cardiac Arrest therapy, Percutaneous Coronary Intervention
- Abstract
Background In patients with out-of-hospital cardiac arrest without ST-segment elevation, immediate coronary angiography did not improve clinical outcomes when compared with delayed angiography in the COACT (Coronary Angiography After Cardiac Arrest) trial. Whether 1 of the 2 strategies has benefits in terms of health care resource use and costs is currently unknown. We assess the health care resource use and costs in patients with out-of-hospital cardiac arrest. Methods and Results A total of 538 patients were randomly assigned to a strategy of either immediate or delayed coronary angiography. Detailed health care resource use and cost-prices were collected from the initial hospital episode. A generalized linear model and a gamma distribution were performed. Generic quality of life was measured with the RAND-36 and collected at 12-month follow-up. Overall total mean costs were similar between both groups (EUR 33 575±19 612 versus EUR 33 880±21 044; P =0.86). Generalized linear model: (β, 0.991; 95% CI, 0.894-1.099; P =0.86). Mean procedural costs (coronary angiography and percutaneous coronary intervention, coronary artery bypass graft) were higher in the immediate angiography group (EUR 4384±3447 versus EUR 3028±4220; P <0.001). Costs concerning intensive care unit and ward stay did not show any significant difference. The RAND-36 questionnaire did not differ between both groups. Conclusions The mean total costs between patients with out-of-hospital cardiac arrest randomly assigned to an immediate angiography or a delayed invasive strategy were similar during the initial hospital stay. With respect to the higher invasive procedure costs in the immediate group, a strategy awaiting neurological recovery followed by coronary angiography and planned revascularization may be considered. Registration URL: https://trialregister.nl; Unique identifier: NL4857.
- Published
- 2022
- Full Text
- View/download PDF
21. Targeted Temperature Management in Out-of-Hospital Cardiac Arrest With Shockable Rhythm: A Post Hoc Analysis of the Coronary Angiography After Cardiac Arrest Trial.
- Author
-
Spoormans EM, Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, Girbes ARJ, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, van de Ven PM, van Royen N, and Elbers PWG
- Subjects
- Aged, Coronary Angiography statistics & numerical data, Female, Humans, Hypothermia, Induced methods, Hypothermia, Induced statistics & numerical data, Male, Middle Aged, Netherlands, Out-of-Hospital Cardiac Arrest epidemiology, Resuscitation methods, Resuscitation statistics & numerical data, Treatment Outcome, Coronary Angiography methods, Electric Countershock statistics & numerical data, Hypothermia, Induced standards, Out-of-Hospital Cardiac Arrest therapy
- Abstract
Objectives: The optimal targeted temperature in patients with shockable rhythm is unclear, and current guidelines recommend targeted temperature management with a correspondingly wide range between 32°C and 36°C. Our aim was to study survival and neurologic outcome associated with targeted temperature management strategy in postarrest patients with initial shockable rhythm., Design: Observational substudy of the Coronary Angiography after Cardiac Arrest without ST-segment Elevation trial., Setting: Nineteen hospitals in The Netherlands., Patients: The Coronary Angiography after Cardiac Arrest trial randomized successfully resuscitated patients with shockable rhythm and absence of ST-segment elevation to a strategy of immediate or delayed coronary angiography. In this substudy, 459 patients treated with mild therapeutic hypothermia (32.0-34.0°C) or targeted normothermia (36.0-37.0°C) were included. Allocation to targeted temperature management strategy was at the discretion of the physician., Interventions: None., Measurements and Main Results: After 90 days, 171 patients (63.6%) in the mild therapeutic hypothermia group and 129 (67.9%) in the targeted normothermia group were alive (hazard ratio, 0.86 [95% CI, 0.62-1.18]; log-rank p = 0.35; adjusted odds ratio, 0.89; 95% CI, 0.45-1.72). Patients in the mild therapeutic hypothermia group had longer ICU stay (4 d [3-7 d] vs 3 d [2-5 d]; ratio of geometric means, 1.32; 95% CI, 1.15-1.51), lower blood pressures, higher lactate levels, and increased need for inotropic support. Cerebral Performance Category scores at ICU discharge and 90-day follow-up and patient-reported Mental and Physical Health Scores at 1 year were similar in the two groups., Conclusions: In the context of out-of-hospital cardiac arrest with shockable rhythm and no ST-elevation, treatment with mild therapeutic hypothermia was not associated with improved 90-day survival compared with targeted normothermia. Neurologic outcomes at 90 days as well as patient-reported Mental and Physical Health Scores at 1 year did not differ between the groups., Competing Interests: Dr. Lemkes received funding from The Netherlands Heart Institute (NHLI) and Biotronik. Drs. Lemkes and Vlachojannis received funding from AstraZeneca. Dr. Rijpstra’s institution received funding from Principle Investigator. Dr. Vlachojannis’ institution received funding from MicroPort and Daiichi Sankyo; he received funding from Abbott. Dr. Vlachojannis reports receiving grant support from MicroPort Orthopedics and Daiichi Sankyo. Dr. van Royen’s institution received funding from Biotronik, AstraZeneca, the NHLI, Abbott, and Medtronic; he received funding from Novartis, MicroPort, Castor, Rainmed, Biotronik, Abbott, Medtronic, and Philips; he received support for article research from the NLHI. The remaining authors have disclosed that they do not have any potential conflicts of interest., (Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.)
- Published
- 2022
- Full Text
- View/download PDF
22. Comprehensive Profiling of Mammalian Tribbles Interactomes Implicates TRIB3 in Gene Repression.
- Author
-
Hernández-Quiles M, Baak R, Borgman A, den Haan S, Sobrevals Alcaraz P, van Es R, Kiss-Toth E, Vos H, and Kalkhoven E
- Abstract
The three human Tribbles (TRIB) pseudokinases have been implicated in a plethora of signaling and metabolic processes linked to cancer initiation and progression and can potentially be used as biomarkers of disease and prognosis. While their modes of action reported so far center around protein-protein interactions, the comprehensive profiling of TRIB interactomes has not been reported yet. Here, we have developed a robust mass spectrometry (MS)-based proteomics approach to characterize Tribbles' interactomes and report a comprehensive assessment and comparison of the TRIB1, -2 and -3 interactomes, as well as domain-specific interactions for TRIB3. Interestingly, TRIB3, which is predominantly localized in the nucleus, interacts with multiple transcriptional regulators, including proteins involved in gene repression. Indeed, we found that TRIB3 repressed gene transcription when tethered to DNA in breast cancer cells. Taken together, our comprehensive proteomic assessment reveals previously unknown interacting partners and functions of Tribbles proteins that expand our understanding of this family of proteins. In addition, our findings show that MS-based proteomics provides a powerful tool to unravel novel pseudokinase biology.
- Published
- 2021
- Full Text
- View/download PDF
23. Stereotactic Body Radiation Therapy after Chemotherapy for Unresectable Perihilar Cholangiocarcinoma: The STRONG Trial, a Phase I Safety and Feasibility Study.
- Author
-
Baak R, Willemssen FEJA, van Norden Y, Eskens FALM, Milder MTW, Heijmen BJM, Koerkamp BG, Sprengers D, van Driel LMJW, Klümpen HJ, den Toom W, Koedijk MS, IJzermans JNM, and Méndez Romero A
- Abstract
Background: In unresectable pCCA, the standard of care is palliative chemotherapy. We investigated the feasibility and safety of adding stereotactic body radiation therapy (SBRT) after chemotherapy., Methods: Patients with unresectable pCCA, stage T1-T4N0-N1M0, ECOG 0-1, having finished 6-8 cycles of cisplatin and gemcitabine without disease progression were eligible. SBRT was planned in 15 fractions of 3.0-4.5 Gy. The primary endpoints were feasibility (defined as completing SBRT as planned) and toxicity, evaluated within 3 months after SBRT (CTCAE v4.03). A conventional "3 + 3" design was used, corresponding to a sample size of 6 patients. Dose-limiting toxicity (DLT) was defined as grade ≥ 4 hepatobiliary or grade ≥ 3 gastrointestinal toxicity. The secondary endpoints, measured from the start of radiotherapy, were local control, progression-free survival, overall survival, and quality of life (QoL). ClinicalTrials.gov identifier: NCT03307538., Results: Six patients were enrolled between November 2017 and March 2020. SBRT was delivered as planned. All patients were treated with 60Gy (15 × 4.0Gy). No SBRT-related DLT was observed. The most common grade ≥ 3 toxicity was cholangitis ( n = 5). The median follow-up was 14 months. The 12-month local control rate was 80%. We observed no substantial changes in QoL., Conclusion: In patients with unresectable pCCA with stable disease after palliative chemotherapy, adding SBRT is feasible and safe. The observed local control merits an additional evaluation of effectiveness.
- Published
- 2021
- Full Text
- View/download PDF
24. The effect of immediate coronary angiography after cardiac arrest without ST-segment elevation on left ventricular function. A sub-study of the COACT randomised trial.
- Author
-
Lemkes JS, Spoormans EM, Demirkiran A, Leutscher S, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, van de Ven PM, van Loon RB, and van Royen N
- Subjects
- Coronary Angiography, Humans, Netherlands, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Out-of-Hospital Cardiac Arrest diagnostic imaging, Out-of-Hospital Cardiac Arrest therapy, Percutaneous Coronary Intervention
- Abstract
Background: The effect of immediate coronary angiography and percutaneous coronary intervention (PCI) in patients who are successfully resuscitated after cardiac arrest in the absence of ST-segment elevation myocardial infarction (STEMI) on left ventricular function is currently unknown., Methods: This prespecified sub-study of a multicentre trial evaluated 552 patients, successfully resuscitated from out-of-hospital cardiac arrest without signs of STEMI. Patients were randomized to either undergo immediate coronary angiography or delayed coronary angiography, after neurologic recovery. All patients underwent PCI if indicated. The main outcomes of this analysis were left ventricular ejection fraction and end-diastolic and systolic volumes assessed by cardiac magnetic resonance imaging or echocardiography., Results: Data on left ventricular function was available for 397 patients. The mean (± standard deviation) left ventricular ejection fraction was 45.2% (±12.8) in the immediate angiography group and 48.4% (±13.2) in the delayed angiography group (mean difference: -3.19; 95% confidence interval [CI], -6.75 to 0.37). Median left ventricular end-diastolic volume was 177 ml in the immediate angiography group compared to 169 ml in the delayed angiography group (ratio of geometric means: 1.06; 95% CI, 0.95-1.19). In addition, mean left ventricular end-systolic volume was 90 ml in the immediate angiography group compared to 78 ml in the delayed angiography group (ratio of geometric means: 1.13; 95% CI 0.97-1.32)., Conclusion: In patients successfully resuscitated after out-of-hospital cardiac arrest and without signs of STEMI, immediate coronary angiography was not found to improve left ventricular dimensions or function compared with a delayed angiography strategy., Clinical Trial Registration: Netherlands Trial Register number, NTR4973., Competing Interests: Declaration of Competing Interest The authors report no declarations of interest., (Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
25. Sex differences in patients with out-of-hospital cardiac arrest without ST-segment elevation: A COACT trial substudy.
- Author
-
Spoormans EM, Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, van de Ven PM, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, der Harst PV, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, Appelman Y, and van Royen N
- Subjects
- Coronary Angiography, Female, Humans, Male, Netherlands epidemiology, Sex Characteristics, Out-of-Hospital Cardiac Arrest therapy, Percutaneous Coronary Intervention, ST Elevation Myocardial Infarction
- Abstract
Background: Whether sex is associated with outcomes of out-of-hospital cardiac arrest (OHCA) is unclear., Objectives: This study examined sex differences in survival in patients with OHCA without ST-segment elevation myocardial infarction (STEMI)., Methods: Using data from the randomized controlled Coronary Angiography after Cardiac Arrest (COACT) trial, the primary point of interest was sex differences in OHCA-related one-year survival. Secondary points of interest included the benefit of immediate coronary angiography compared to delayed angiography until after neurologic recovery, angiographic and clinical outcomes., Results: In total, 522 patients (79.1% men) were included. Overall one-year survival was 59.6% in women and 63.4% in men (HR 1.18; 95% CI: 0.76-1.81;p = 0.47). No cardiovascular risk factors were found that modified survival. Women less often had significant coronary artery disease (CAD) (37.0% vs. 71.3%;p < 0.001), but when present, they had a worse prognosis than women without CAD (HR 3.06; 95% CI 1.31-7.19;p = 0.01). This was not the case for men (HR 1.05; 95% CI 0.67-1.65;p = 0.83). In both sexes, immediate coronary angiography did not improve one-year survival compared to delayed angiography (women, odds ratio (OR) 0.87; 95% CI 0.58-1.30;p = 0.49; vs. men, OR 0.97; 95% CI 0.45-2.09;p = 0.93)., Conclusion: In OHCA patients without STEMI, we found no sex differences in overall one-year survival. Women less often had significant CAD, but when CAD was present they had worse survival than women without CAD. This was not the case for men. Both sexes did not benefit from a strategy of immediate coronary angiography as compared to delayed strategy with respect to one-year survival., Clinical Trial Registration Number: Netherlands trial register (NTR) 4973., (Copyright © 2020. Published by Elsevier B.V.)
- Published
- 2021
- Full Text
- View/download PDF
26. Data on sex differences in one-year outcomes of out-of-hospital cardiac arrest patients without ST-segment elevation.
- Author
-
Spoormans EM, Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, van de Ven PM, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, Appelman Y, and van Royen N
- Abstract
Sex differences in out-of-hospital cardiac arrest (OHCA) patients are increasingly recognized. Although it has been found that post-resuscitated women are less likely to have significant coronary artery disease (CAD) than men, data on follow-up in these patients are limited. Data for this data in brief article was obtained as a part of the randomized controlled Coronary Angiography after Cardiac Arrest without ST-segment elevation (COACT) trial. The data supplements the manuscript "Sex differences in out-of-hospital cardiac arrest patients without ST-segment elevation: A COACT trial substudy" were it was found that women were less likely to have significant CAD including chronic total occlusions, and had worse survival when CAD was present. The dataset presented in this paper describes sex differences on interventions, implantable-cardioverter defibrillator (ICD) shocks and hospitalizations due to heart failure during one-year follow-up in patients successfully resuscitated after OHCA. Data was derived through a telephone interview at one year with the patient or general practitioner. Patients in this randomized dataset reflects a homogenous study population, which can be valuable to further build on research regarding long-term sex differences and to further improve cardiac care., Competing Interests: Supported by unrestricted research grants from the Netherlands Heart Institute, Biotronik, and AstraZeneca. Dr. Vlachojannis reports receiving grant support from MicroPort Orthopedics and Daiichi Sankyo; and Dr. van Royen, receiving grant support from Philips, Biotronik, and Abbott and honoraria from Medtronic. No other potential conflict of interest relevant to this article was reported., (© 2020 The Authors.)
- Published
- 2020
- Full Text
- View/download PDF
27. Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
- Author
-
Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, van de Ven PM, Oudemans-van Straaten HM, and van Royen N
- Subjects
- Aged, Female, Heart Diseases complications, Heart Diseases therapy, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Out-of-Hospital Cardiac Arrest mortality, Out-of-Hospital Cardiac Arrest therapy, Coronary Angiography, Electrocardiography, Heart Diseases diagnostic imaging, Out-of-Hospital Cardiac Arrest diagnostic imaging, Percutaneous Coronary Intervention, Time-to-Treatment
- Abstract
Background: Ischemic heart disease is a major cause of out-of-hospital cardiac arrest. The role of immediate coronary angiography and percutaneous coronary intervention (PCI) in the treatment of patients who have been successfully resuscitated after cardiac arrest in the absence of ST-segment elevation myocardial infarction (STEMI) remains uncertain., Methods: In this multicenter trial, we randomly assigned 552 patients who had cardiac arrest without signs of STEMI to undergo immediate coronary angiography or coronary angiography that was delayed until after neurologic recovery. All patients underwent PCI if indicated. The primary end point was survival at 90 days. Secondary end points included survival at 90 days with good cerebral performance or mild or moderate disability, myocardial injury, duration of catecholamine support, markers of shock, recurrence of ventricular tachycardia, duration of mechanical ventilation, major bleeding, occurrence of acute kidney injury, need for renal-replacement therapy, time to target temperature, and neurologic status at discharge from the intensive care unit., Results: At 90 days, 176 of 273 patients (64.5%) in the immediate angiography group and 178 of 265 patients (67.2%) in the delayed angiography group were alive (odds ratio, 0.89; 95% confidence interval [CI], 0.62 to 1.27; P = 0.51). The median time to target temperature was 5.4 hours in the immediate angiography group and 4.7 hours in the delayed angiography group (ratio of geometric means, 1.19; 95% CI, 1.04 to 1.36). No significant differences between the groups were found in the remaining secondary end points., Conclusions: Among patients who had been successfully resuscitated after out-of-hospital cardiac arrest and had no signs of STEMI, a strategy of immediate angiography was not found to be better than a strategy of delayed angiography with respect to overall survival at 90 days. (Funded by the Netherlands Heart Institute and others; COACT Netherlands Trial Register number, NTR4973.)., (Copyright © 2019 Massachusetts Medical Society.)
- Published
- 2019
- Full Text
- View/download PDF
28. Coronary angiography after cardiac arrest: Rationale and design of the COACT trial.
- Author
-
Lemkes JS, Janssens GN, Straaten HM, Elbers PW, van der Hoeven NW, Tijssen JG, Otterspoor LC, Voskuil M, van der Heijden JJ, Meuwissen M, Rijpstra TA, Vlachojannis GJ, van der Vleugel RM, Nieman K, Jewbali LS, Bleeker GB, Baak R, Beishuizen B, Stoel MG, van der Harst P, Camaro C, Henriques JP, Vink MA, Gosselink MT, Bosker HA, Crijns HJ, and van Royen N
- Subjects
- Adult, Humans, Intention to Treat Analysis, Out-of-Hospital Cardiac Arrest diagnostic imaging, Prospective Studies, Research Design, Time-to-Treatment, Coronary Angiography, Out-of-Hospital Cardiac Arrest therapy, Percutaneous Coronary Intervention
- Abstract
Background: Ischemic heart disease is a major cause of out-of-hospital cardiac arrest. The role of immediate coronary angiography (CAG) and percutaneous coronary intervention (PCI) after restoration of spontaneous circulation following cardiac arrest in the absence of ST-segment elevation myocardial infarction (STEMI) remains debated., Hypothesis: We hypothesize that immediate CAG and PCI, if indicated, will improve 90-day survival in post-cardiac arrest patients without signs of STEMI., Design: In a prospective, multicenter, randomized controlled clinical trial, 552 post-cardiac arrest patients with restoration of spontaneous circulation and without signs of STEMI will be randomized in a 1:1 fashion to immediate CAG and PCI (within 2 hours) versus initial deferral with CAG and PCI after neurological recovery. The primary end point of the study is 90-day survival. The secondary end points will include 90-day survival with good cerebral performance or minor/moderate disability, myocardial injury, duration of inotropic support, occurrence of acute kidney injury, need for renal replacement therapy, time to targeted temperature control, neurological status at intensive care unit discharge, markers of shock, recurrence of ventricular tachycardia, duration of mechanical ventilation, and reasons for discontinuation of treatment., Summary: The COACT trial is a multicenter, randomized, controlled clinical study that will evaluate the effect of an immediate invasive coronary strategy in post-cardiac arrest patients without STEMI on 90-day survival., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
29. Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
- Author
-
Pratt VM, Everts RE, Aggarwal P, Beyer BN, Broeckel U, Epstein-Baak R, Hujsak P, Kornreich R, Liao J, Lorier R, Scott SA, Smith CH, Toji LH, Turner A, and Kalman LV
- Subjects
- Base Sequence, Cell Line, Genetic Testing, Genotype, Genotyping Techniques, High-Throughput Nucleotide Sequencing, Humans, Polymorphism, Single Nucleotide genetics, Sequence Analysis, DNA, United States, Carrier Proteins genetics, Cytochrome P-450 Enzyme System genetics, Drug-Related Side Effects and Adverse Reactions genetics, Glucuronosyltransferase genetics, Glutathione Transferase genetics, Pharmacogenetics methods
- Abstract
Pharmacogenetic testing is increasingly available from clinical laboratories. However, only a limited number of quality control and other reference materials are currently available to support clinical testing. To address this need, the Centers for Disease Control and Prevention-based Genetic Testing Reference Material Coordination Program, in collaboration with members of the pharmacogenetic testing community and the Coriell Cell Repositories, has characterized 137 genomic DNA samples for 28 genes commonly genotyped by pharmacogenetic testing assays (CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP4F2, DPYD, GSTM1, GSTP1, GSTT1, NAT1, NAT2, SLC15A2, SLC22A2, SLCO1B1, SLCO2B1, TPMT, UGT1A1, UGT2B7, UGT2B15, UGT2B17, and VKORC1). One hundred thirty-seven Coriell cell lines were selected based on ethnic diversity and partial genotype characterization from earlier testing. DNA samples were coded and distributed to volunteer testing laboratories for targeted genotyping using a number of commercially available and laboratory developed tests. Through consensus verification, we confirmed the presence of at least 108 variant pharmacogenetic alleles. These samples are also being characterized by other pharmacogenetic assays, including next-generation sequencing, which will be reported separately. Genotyping results were consistent among laboratories, with most differences in allele assignments attributed to assay design and variability in reported allele nomenclature, particularly for CYP2D6, UGT1A1, and VKORC1. These publicly available samples will help ensure the accuracy of pharmacogenetic testing., (Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
30. Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.
- Author
-
Pratt VM, Zehnbauer B, Wilson JA, Baak R, Babic N, Bettinotti M, Buller A, Butz K, Campbell M, Civalier C, El-Badry A, Farkas DH, Lyon E, Mandal S, McKinney J, Muralidharan K, Noll L, Sander T, Shabbeer J, Smith C, Telatar M, Toji L, Vairavan A, Vance C, Weck KE, Wu AH, Yeo KT, Zeller M, and Kalman L
- Subjects
- Alleles, Cell Line, Cytochrome P-450 CYP2C19, Cytochrome P-450 CYP2C9, DNA genetics, Genome, Human, Genotype, Humans, Pathology, Molecular instrumentation, Pathology, Molecular methods, Vitamin K Epoxide Reductases, Aryl Hydrocarbon Hydroxylases genetics, Cytochrome P-450 CYP2D6 genetics, Genetic Markers, Glucuronosyltransferase genetics, Mixed Function Oxygenases genetics, Pharmacogenetics instrumentation, Pharmacogenetics methods
- Abstract
Pharmacogenetic testing is becoming more common; however, very few quality control and other reference materials that cover alleles commonly included in such assays are currently available. To address these needs, the Centers for Disease Control and Prevention's Genetic Testing Reference Material Coordination Program, in collaboration with members of the pharmacogenetic testing community and the Coriell Cell Repositories, have characterized a panel of 107 genomic DNA reference materials for five loci (CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1) that are commonly included in pharmacogenetic testing panels and proficiency testing surveys. Genomic DNA from publicly available cell lines was sent to volunteer laboratories for genotyping. Each sample was tested in three to six laboratories using a variety of commercially available or laboratory-developed platforms. The results were consistent among laboratories, with differences in allele assignments largely related to the manufacturer's assay design and variable nomenclature, especially for CYP2D6. The alleles included in the assay platforms varied, but most were identified in the set of 107 DNA samples. Nine additional pharmacogenetic loci (CYP4F2, EPHX1, ABCB1, HLAB, KIF6, CYP3A4, CYP3A5, TPMT, and DPD) were also tested. These samples are publicly available from Coriell and will be useful for quality assurance, proficiency testing, test development, and research.
- Published
- 2010
- Full Text
- View/download PDF
31. Pharmacogenetic testing for clopidogrel using the rapid INFINITI analyzer: a dose-escalation study.
- Author
-
Gladding P, White H, Voss J, Ormiston J, Stewart J, Ruygrok P, Bvaldivia B, Baak R, White C, and Webster M
- Subjects
- Aged, Aryl Hydrocarbon Hydroxylases metabolism, Clopidogrel, Cytochrome P-450 CYP2C19, Cytochrome P-450 CYP2C9, Dose-Response Relationship, Drug, Drug Resistance genetics, Equipment Design, Female, Gene Frequency, Genotype, Humans, Male, Middle Aged, Phenotype, Platelet Aggregation genetics, Platelet Aggregation Inhibitors metabolism, Polymorphism, Single Nucleotide, Precision Medicine, Predictive Value of Tests, Randomized Controlled Trials as Topic, Retrospective Studies, Ticlopidine administration & dosage, Ticlopidine metabolism, Time Factors, Angioplasty, Balloon, Coronary, Aryl Hydrocarbon Hydroxylases genetics, Oligonucleotide Array Sequence Analysis instrumentation, Pharmacogenetics instrumentation, Platelet Aggregation drug effects, Platelet Aggregation Inhibitors administration & dosage, Platelet Function Tests instrumentation, Ticlopidine analogs & derivatives
- Abstract
Objectives: Our aim was to assess whether a higher clopidogrel maintenance dose has a greater antiplatelet effect in CYP2C19*2 allele carriers compared with noncarriers., Background: Clopidogrel is a prodrug that is biotransformed by the cytochrome P450 enzymes CYP2C19, 2C9, and 3A4, 2B6, 1A2. The CYPC219*2 loss of function variant has been associated with a reduced antiplatelet response to clopidogrel and a 3-fold risk of stent thrombosis., Methods: Forty patients on standard maintenance dosage clopidogrel (75 mg), for 9.4 +/- 9.2 weeks, were enrolled into a dose escalation study. Platelet function was assessed at baseline and after 1 week of 150 mg once daily using the VerifyNow platelet function analyzer (Accumetrics Ltd., San Diego, California). Genomic DNA was hybridized to a BioFilmChip microarray on the INFINITI analyzer (AutoGenomics Inc., Carlsbad, California) and analyzed for the CYP19*2, *4, *17, and CYP2C9*2, *3 polymorphisms., Results: Platelet inhibition increased over 1 week, mean +8.6 +/- 13.5% (p = 0.0003). Carriers of the CYP2C19*2 allele had significantly reduced platelet inhibition at baseline (median 18%, range 0% to 72%) compared with wildtype (wt) (median 59%, range 11% to 95%, p = 0.01) and at 1 week (p = 0.03). CYP2C19*2 allele carriers had an increase in platelet inhibition of (mean +9 +/- 11%, p = 0.03) and reduction in platelet reactivity (mean -26 +/- 38 platelet response unit, p = 0.04) with a higher dose. Together CYP2C19*2 and CYP2C9*3 loss of function carriers had a greater change in platelet inhibition with 150 mg daily than wt/wt (+10.9% vs. +0.7%, p = 0.04)., Conclusions: Increasing the dose of clopidogrel in patients with nonresponder polymorphisms can increase antiplatelet response. Personalizing clopidogrel dosing using pharmacogenomics may be an effective method of optimizing treatment.
- Published
- 2009
- Full Text
- View/download PDF
32. Coronary artery bypass grafting after primary isolated aortic valve surgery.
- Author
-
Takkenberg JJ, Denton TA, Baak R, Trento A, Steyerberg EW, and van Herwerden LA
- Subjects
- Cohort Studies, Female, Follow-Up Studies, Humans, Male, Mammary Arteries injuries, Middle Aged, Minimally Invasive Surgical Procedures, Reoperation statistics & numerical data, Survival Analysis, Time Factors, Aortic Valve surgery, Coronary Artery Bypass statistics & numerical data
- Published
- 1999
- Full Text
- View/download PDF
33. Inducible transformation of cells from transgenic mice expressing SV40 under lac operon control.
- Author
-
Epstein-Baak R, Lin Y, Bradshaw V, and Cohn M
- Subjects
- Animals, Antibodies, Monoclonal, Base Sequence, Cells, Cultured drug effects, Gene Expression drug effects, Mice, Mice, Transgenic, Molecular Sequence Data, Tail cytology, Antigens, Polyomavirus Transforming genetics, Isopropyl Thiogalactoside pharmacology, Lac Operon, Transformation, Genetic drug effects
- Abstract
If it were possible to clone in vitro cells of any type, at any stage of differentiation, from an extensively characterized animal such as the mouse, many areas of cell biology would benefit. Indeed, it would be even more helpful if these cells could subsequently be restored to their normal in vivo phenotype whenever required. Here, we describe a step on the pathway to such an idealized "clonable" mouse. In principle, it seeks to link a "universal" transforming agent to a regulatory system that is relatively simple, yet quite foreign to the mouse. A plasmid containing the bacterial lac operator/promoter region linked to the SV40 large T antigen and a vector containing the lac repressor that can be expressed in mammalian cells were coinjected into fertilized mouse oocytes utilizing the standard techniques for generating transgenic mice. Two progeny were obtained that express large T antigen in the presence, but not the absence, of the nonmetabolizable lac inducer, isopropyl-beta-thio-D-galactoside. This report characterizes fibroblast cell lines established from these transgenics that are readily transformed in vitro with isopropyl-beta-thio-D-galactoside. A significant proportion of the cells are restored to their "normal" (nontransformed phenotype) when isopropyl-beta-thio-D-galactoside is removed.
- Published
- 1992
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.